Assenagon Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $221M | Buy |
|
|||||
|
2025
Q2 | $120M | Sell |
|
|||||
|
2025
Q1 | $255M | Buy |
|
|||||
|
2024
Q4 | $65.4M | Sell |
|
|||||
|
2024
Q3 | $150M | Buy |
|
|||||
|
2024
Q2 | $133M | Sell |
|
|||||
|
2024
Q1 | $166M | Sell |
|
|||||
|
2023
Q4 | $183M | Buy |
|
|||||
|
2023
Q3 | $139M | Buy |
|
|||||
|
2023
Q2 | $113M | Sell |
|
|||||
|
2023
Q1 | $280M | Buy |
|
|||||
|
2022
Q4 | $163M | Sell |
|
|||||
|
2022
Q3 | $543M | Buy |
|
|||||
|
2022
Q2 | $103M | Sell |
|
|||||
|
2022
Q1 | $238M | Buy |
|
|||||
|
2021
Q4 | $222M | Buy |
|
|||||
|
2021
Q3 | $162M | Buy |
|
|||||
|
2021
Q2 | $129M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $34.3M | Buy |
|
|||||
|
2020
Q3 | $28.1M | Buy |
|
|||||
|
2020
Q2 | $233K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $3.23M | Buy |
|
|||||
|
2019
Q3 | $269K | Sell |
|
|||||
|
2019
Q2 | $142M | Buy |
|
|||||
|
2019
Q1 | $849K | Sell |
|
|||||
|
2018
Q4 | $75.6M | Sell |
|
|||||
|
2018
Q3 | $96.1M | Buy |
|
|||||
|
2018
Q2 | $10.9M | Sell |
|
|||||
|
2018
Q1 | $22.5M | Buy |
|
|||||
|
2017
Q4 | $1.18M | Sell |
|
|||||
|
2017
Q3 | $67.8M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $6.73M | Buy |
|